Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial

REFERENCES

• Pederson JE., Hypotony. In Tasman W, Jaeger EA, eds. Duane’s Clinical Ophthalmology. Philadelphia, PA: Lippincott-Raven; 1999:1–8.
   Google Scholar
• Schubert HD. Postsurgical hypotony: relationship to fistulization, inflammation, chorioretinal lesions and the vitreous. Surv Ophthalmol. 1996;41(2):97–125.
   PubMedGoogle Scholar
• Toris CB, Pederson JE. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci. 1987;28(3):477–481.
   PubMedGoogle Scholar
• Tran VT, Mermoud A, Herbort CP. Appraisal and management of ocular hypotony and glaucoma associated with uveitis. Int Ophthalmol Clin. 2000:40(2):175–203.
   PubMedGoogle Scholar
• Kim HC, Hayashi A, Shalash A, de Juan E Jr. A model of chronic hypotony in the rabbit. Graefes Arch Clin Exp Ophthalmol. 1998;236(1):69–74.
   PubMedGoogle Scholar
• Loh AR, Acharya NR. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol. 2010;150(4):534–542.
   PubMedGoogle Scholar
• Tugal-Tutkun I, Havrlikova K, Power WJ, et al. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103(3):375–383.
   PubMedGoogle Scholar
• Kump LI, Castañeda RA, Androudi SN, et al. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology. 2006;113(10):1874–1877.
   PubMedGoogle Scholar
• Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143(5):840–846.
   PubMedGoogle Scholar
• Kaçmaz RO, Kempen JH, Newcomb C, et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146(6):828–836.
   PubMed Web of Science ®Google Scholar
• Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116(8):1544–1551.
   PubMed Web of Science ®Google Scholar
• O’Connell SR, Majji AB, Humayun MS, et al. The surgical management of hypotony. Ophthalmology. 2000;107(2):318–323.
   PubMedGoogle Scholar
• Jonas JB, Vossmerbaeumer U, Kamppeter BA. Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide. Acta Ophthalmol Scand. 2004;82(5):637.
   PubMedGoogle Scholar
• Ugahary LC, Ganteris E, Veckeneer M, et al. Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. Am J Ophthalmol. 2006;141(3):571–573.
   PubMedGoogle Scholar
• Friedman SM, Mahootchi A. The use of intravitreal gas for the treatment of ocular hypotony after glaucoma filtration surgery. Ophthalmic Surg Lasers Imaging. 2006;37(3):234–235.
   PubMedGoogle Scholar
• Kapur R, Birnbaum AD, Goldstein DA, et al. Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Retina. 2010;30(1):140–145.
   PubMedGoogle Scholar
• Kucukerdonmez C, Beutel J, Bartz-Schmidt KU, et al. Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate. Br J Ophthalmol. 2009;93(2):235–239.
   PubMedGoogle Scholar
• Tosi GM, Schiff W, Barile G, et al. Management of severe hypotony with intravitreal injection of viscoelastic. Am J Ophthalmol. 2005;140(5):952–954.
   PubMedGoogle Scholar
• Gupta P, Gupta A, Gupta V, et al. Successful outcome of pars plana vitreous surgery in chronic hypotony due to uveitis. Retina. 2009;29(5):638–643.
   PubMedGoogle Scholar
• Yu EN, Paredes I, Foster CS. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2007;15(1):11–17.
   PubMedGoogle Scholar
• , Multicenter Uveitis Steroid Treatment (MUST) Trial Research GroupKempen JH, Altaweel MM, Holbrook JT, et al. The Multicenter Uveitis Steroid Treatment Trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010; 149(4):550–561.
   PubMedGoogle Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. Inter-observer variation in refraction and visual acuity measurement using a standardized protocol. Ophthalmology. 1983;90(11):1357–1359.
   PubMedGoogle Scholar
• Tugal-Tutkun I, Aydin-Akova Y, Güney-Tefekli E, et al. Referral patterns, demographic and clinical features, and visual prognosis of Turkish patients with sarcoid uveitis. Ocul Immunol Inflamm. 2007;15(4):337–343.
   PubMedGoogle Scholar
• Khalatbari D, Stinnett S, McCallum RM, Jaffe GJ. Demographic-related variations in posterior segment ocular sarcoidosis. Ophthalmology. 2004;111(2):357–362.
   PubMedGoogle Scholar
• Braakenburg AM, de Valk HW, de Boer J, Rothova A. Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol. 2008; 145(3):472– 479.
   PubMedGoogle Scholar
• Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001 May;131(5):599–606.
   PubMedGoogle Scholar
• Thomas, KW, Hunninghake, GW. Sarcoidosis. JAMA. 2003;289(24):3300–3303.
   PubMedGoogle Scholar
• Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336(17):1224–1234.
   PubMedGoogle Scholar
• Lindsey JD, Weinreb RN. Effects of prostaglandins on uveoscleral outflow. In Alm A, Weinreb RN, eds. Uveoscleral Outflow. London, England: Mosby-Wolfe; 1998: 41–55.
   Google Scholar